MAY 2022LIFE SCIENCES REVIEW8n 2020, global healthcare investments reached a record high, and the median size of deals increases every year. While breakthroughs in health science drive this growth, human change is an increasingly important driver, particularly the deepening recognition of the ties between health and happiness.The COVID pandemic has greatly accelerated this process. Trapped at home, people became hyper-conscious of staying healthy and took over aspects of wellness and care previously reserved for professionals. At-home care is on the rise, using data, wearables, and VR to make care, prevention, and personal maximization more accessible. Products aimed at mental health proliferate because COVID-isolated people are under enormous stress and can largely only access services remotely. Virtual ageing-at-home services have also seen a huge leap in adoption as the senior living industry has finally entered the digital age. Similarly, aspects of women's health such as menopause treatments, fertility solutions, personalized platforms for maternal, child, and sexual wellness are becoming increasingly mainstream.Our funds focus specifically on the juncture between health science and individual happiness. Our primary investment areas today:Longevity and AgeingWhen it comes to getting older, the numbers tell a tale of dramatic growth: By 2050, the 65+ population in the US will double. That population will have the highest net worth of any age category in the US; Boomers are already the wealthiest generation in history. The world's current population is 7.79 billion, with 727 million of those are age 65 and older. By 2030, there will be almost 1 billion over the age of 65 on the globe. Those 1 billion people will expect to live longer and better lives. It will be natural for those 65-year-olds to expect 20-25 By Mike Edelhart, Managing Partner, Ataraxia VCBIOTECH'S EMERGING CONTRIBUTION TO HEALTH AND HAPPINESSIIN MY OPINION
< Page 7 | Page 9 >